Becton, Dickinson and Company (BDX) , popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe, expanding its Neopak Glass Prefillable Syringe platform to address the growing demand for biologic therapies.The platform, now approved for more than 24 medical indications, is designed to enhance usability for high-viscosity drugs. Key improvements include a thinner wall cannula and a shorter 8mm needle length, optimizing drug delivery and reducing injection ...